What Researchers Did
Researchers conducted a systematic review to evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) for musculoskeletal pain syndromes.
What They Found
The review included 18 studies (17 RCTs and 1 case series), suggesting that HBOT may offer adjunctive benefits for musculoskeletal pain syndromes. However, the current evidence is limited, and more high-quality trials are needed to define its clinical applicability.
What This Means for Canadian Patients
Canadian patients with musculoskeletal pain might consider hyperbaric oxygen therapy as an additional treatment option, but should be aware that robust evidence supporting its widespread use is still developing. Consultation with a healthcare provider is essential to understand its potential role and current limitations.
Canadian Relevance
This systematic review does not have a direct Canadian connection.
Study Limitations
A key limitation is the current limited evidence base, necessitating more standardized treatment protocols and high-quality trials.